HSTM vs RMD: fair value comparison
HealthStream, Inc. and ResMed Inc. · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, RMD currently sits closer to the top of our discount ranking. RMD carries the stronger quality grade.
| HSTM | RMD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $28.33 | $228.35 |
| 12-month range | $20.37–$28.33 | $186.44–$257.39 |
| Sector rank | #26 of 113 Healthcare | #24 of 113 Healthcare |
| Quality grade | D | A |
| Momentum grade | B | B |
| Leverage | Low | Low |
| Margin trend | — | Expanding |
| Revenue growth | — | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: HSTM fair value analysis · RMD fair value analysis